Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fungi have enormous potential for new antibiotics

20.04.2017

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from nature's own resources. The findings - which could prove very useful in the battle against antibiotic resistance - were recently published in the journal, Nature Microbiology.

Antibiotics have saved millions of lives since they were discovered in the 1940s. But recently we've had to learn a new term: antibiotic resistance. More and more bacteria are developing their own protection against antibiotics, thereby becoming resistant to treatment. This will lead to simple infections becoming lethal once again. Our need for new antibiotics is urgent.


While Penicillia are already industrially used in the production of antibiotics, other pharmaceuticals, industrial enzymes and in the manufacturing of food products, new research reveals that their potential for production of novel antibiotics is far from exhausted. Penicillia are naturally found in temperate climates growing on organic matter, including soil, plant material, dung and food products. The isolation of novel bioactive compounds from these species might encompass a source of new antibiotics to fight infectious microorganisms.

Credit: Jens Christian Nielsen

The first antibiotic to be mass-produced was penicillin, derived from Penicillium fungi. In their quest for new antibiotics, Chalmers researchers sequenced the genomes of nine different types of Penicillium species. And the findings are amazing:

"We found that the fungi have enormous, previously untapped, potential for the production of new antibiotics and other bioactive compounds, such as cancer medicines," says Jens Christian Nielsen, a PhD student at the Department of Biology and Biological Engineering.

He works in a research team led by another Chalmers researcher with almost the same name: Professor Jens Nielsen.

In the study, recently published in the journal, Nature Microbiology, the research group scanned the genomes of 24 different kinds of fungi to find genes responsible for the production of various bioactive compounds, like antibiotics. More than 1000 pathways were discovered, showing immense potential for fungi to produce a large variety of natural and bioactive chemicals that could be used as pharmaceuticals.

In about 90 cases, the researchers were able to predict the chemical products of the pathways. As evidence of this, they followed the production of the antibiotic, yanuthone, and identified new fungi able to produce the compound, but also that some species could produce a new version of the drug.

All in all, the study shows vast potential for fungi, not only in producing new antibiotics but also in enabling more efficient production of existing ones - and maybe also more effective versions of the existing ones.

"It's important to find new antibiotics in order to give physicians a broad palette of antibiotics, existing ones as well as new ones, to use in treatment. This will make it harder for bacteria to develop resistance," explains Jens Christian Nielsen.

"Previous efforts to find new antibiotics have mainly focused on bacteria. Fungi have been hard to study - we know very little of what they can do - but we do know that they develop bioactive substances naturally, as a way to protect themselves and survive in a competitive environment. This made it logical to apply our research tools to fungi."

Researchers now have various paths to follow. One way of moving forward could be to look further at the production of the new yanuthone compound. The Chalmers researchers have also drawn up a map that makes it possible to compare hundreds of genes in the continuous evaluation of bioactive products with potent drugs in sight.

How long it would take to launch new antibiotics on the market is impossible to say.

"Governments need to act. The pharmaceutical industry doesn't want to spend money on new antibiotics, it's not lucrative. This is why our governments have to step in and, for instance, support clinical studies. Their support would make it easier to reach the market, especially for smaller companies. This could fuel production," says Jens Christian Nielsen.

Johanna Wilde | EurekAlert!

Further reports about: Penicillium antibiotic antibiotics bacteria bioactive bioactive compounds fungi

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>